Line Andersen has extensive experience in global market access, particularly within the pharmaceutical industry, currently serving as a Senior Global Market Access Principal at LEO Pharma since March 2013. In this role, responsibilities include guiding clinical trial design to incorporate market access considerations and project managing the development of core value dossiers and market access support tools. Prior experience includes roles at ALK Abelló, where Line Andersen focused on optimizing pricing and reimbursement outcomes, as well as supporting health economics efforts for marketed products. Educational background includes a Master's degree in Public Health from the University of Copenhagen and a Bachelor's degree in Public Health from the University of Southern Denmark.
This person is not in the org chart
This person is not in any teams
This person is not in any offices